Skip to content

Evaluation of an Analgosedation Protocol in Mechanically Ventilated Patients

Evaluation of an Analgosedation Protocol in Mechanically Ventilated Patients

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02100735
Enrollment
0
Registered
2014-04-01
Start date
2019-09-13
Completion date
2021-04-30
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of Protocolized Sedation on Days of Mechanical Ventilation in the ICU

Keywords

sedatives, analgesics, protocol, mechanical ventilation, analgosedation

Brief summary

The purpose of this study is to evaluate how the investigators provide sedation (medicine that make you sleepy) in the investigators intensive care unit (ICU). This study will look at a new way of using sedation in the ICU to see what effect it has on patients and if it decreases the amount of time spent on mechanical ventilation (machine that breathes for you), and in the ICU.

Interventions

Nursing driven sedation protocol

Sponsors

Tampa General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients 18 years of age and older * Patients expected to require mechanical ventilation for greater than 48 hrs

Exclusion criteria

* Need for continuous neuromuscular blockade * Severe chronic neurocognitive dysfunction * Tracheostomy at the time of study enrollment * Alcohol withdrawal risk or symptoms * Drug overdose * Chronic use of narcotics * Active seizures

Design outcomes

Primary

MeasureTime frame
Days on mechanical ventilationParticipants will be assessed daily for the duration of their stay in the ICU, an expected average of 4-5 days

Secondary

MeasureTime frame
ICU Length of stayParticipants will be followed for the entire length of their ICU stay, expected average of 4-7 days
28 day mortalityParticipants will be followed for 28 days from enrollment into the study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026